Related MeSH Hierarchy (4)
Diseases [C] » Infections [C01] » Respiratory Tract Infections » Rhinitis
Diseases [C] » Respiratory Tract Diseases [C08] » Nose Diseases » Rhinitis
Diseases [C] » Respiratory Tract Diseases [C08] » Respiratory Tract Infections » Rhinitis
Diseases [C] » Otorhinolaryngologic Diseases [C09] » Nose Diseases » Rhinitis
Description
Inflammation of the NASAL MUCOSA, the mucous membrane lining the NASAL CAVITIES. MeSH
Hierarchy View
Subtype Terms (3)
Rhinitis, Allergic
159 drugs (60 approved, 99 experimental)
Rhinitis, Atrophic
1 approved drug
Rhinitis, Vasomotor
10 drugs (9 approved, 1 experimental)
Approved Indicated Drugs (4)
Phase 4 Indicated Drugs (13)
Phase 3 Indicated Drugs (18)
Other Experimental Indicated Drugs (11)
Organization Involved with Phase 4 Indications (87)
AAADRS Clinical Research Center
Biogenics Research Chamber, LLC
California Allergy and Asthma Medical Group, Inc.
Hoosier Cancer Research Network
Institut für Atemwegsforschung GmbH
Instituto di Biomedicina ed immunologia molecolare
Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Istituto per la Ricerca e l'Innovazione Biomedica
Iuliu Hatieganu University of Medicine and Pharmacy
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Child Health Karachi.
National Institutes of Health (NIH)
National Research Council of Thailand
New York City Health and Hospitals Corporation
Scottish Centre for Respiratory Reseach
Organization Involved with Phase 3 Indications (107)
Ache Laboratorios Farmaceuticos S.A.
Ahn-Gook Pharmaceuticals Co.,Ltd
Allergisa Pesquisa Dermato-Cosmetica LTDA
Allergists and Immunologists, Fort Lauderdale
Clinical Research International Limited
Clínica Virgen del Rosario, Algeciras
Committee on Chinese Medicine and Pharmacy
Fondazione Toscana Gabriele Monasterio
Government Pharmaceutical Organization
Guangdong Provincial Hospital of Traditional Chinese Medicine
LAL Clinical Reseach e Development Ltda
National Autonomous University of Mexico
Novum Pharmaceutical Research Services
Organization Involved with Phase 2 Indications (92)
Aeroallergy Research Laboratories
Allergy and Asthma Medical Group and Research Center, San Diego
Allergy & Asthma Consultant, NJ
American Academy of Otolaryngic Allergy
American College of Allergy, Asthma and Immunology
Central Texas Allergy and Asthma
China Academy of Chinese Medical Sciences
Chinese Academy of Medical Sciences
Dynavax Technologies Corporation
Gulf Coast Research Associates, Inc
Hammersmith Medicines Research
Hospital Universitario Infanta Elena
Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust
National Institute of Allergy and Infectious Diseases (NIAID)
National University of Singapore
Northeast Medical Research Associates, Inc.
State University of New York, Brooklyn
Thai Traditional Medical Knowledge Fund
The Hong Kong Polytechnic University
Universidad Complutense de Madrid
University of California, San Diego
University of Colorado, Denver
University of Texas at Houston
Untersuchungszentrum Dermatologie, Allergologie und Asthma, Berlin, Germany
Organization Involved with Phase 1 Indications (33)
Organization Involved with Other Experimental Indications (34)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
